Evaluation of a Low-fluoride Anticaries Toothpaste
Launched by INDIANA NANOTECH, LLC · Mar 25, 2010
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 30 adult subjects (between 18-50 years of age)
About Indiana Nanotech, Llc
Indiana Nanotech, LLC is a pioneering organization dedicated to advancing nanotechnology applications in the biomedical field. With a focus on innovative solutions for drug delivery and therapeutic interventions, the company harnesses the unique properties of nanomaterials to enhance treatment efficacy and patient outcomes. Indiana Nanotech collaborates with leading researchers and institutions to conduct clinical trials that explore the safety and effectiveness of its cutting-edge products. Committed to rigorous scientific standards and regulatory compliance, the company aims to translate groundbreaking research into real-world healthcare solutions that improve the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials